Tonix Pharmaceuticals Holding Corp <TNXP.OQ> expected to post a loss of $3.24 a share - Earnings Preview

• Tonix Pharmaceuticals Holding Corp TNXP.OQ TNXP.O is expected to show a rise in quarterly revenue when it reports results on November 10 (estimated) for the period ending September 30 2025

• The Chatham New Jersey-based company is expected to report a 16.9% increase in revenue to $3.3 million from $2.82 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Tonix Pharmaceuticals Holding Corp is for a loss of $3.24 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts had risen by about 52.1% in the last three months. ​

• Wall Street's median 12-month price target for Tonix Pharmaceuticals Holding Corp is $65.00, about 30.8% above its last closing price of $44.97

This summary was machine generated August 12 at 20:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)